UC a three-time winner of OFC awards
Orthopaedic researcher Chia-Ying “James” Lin wins award for technology that can aid in human tissue growth, repair and prevention
University of Cincinnati researcher and educator Chia-Ying “James” Lin was honored Friday, Oct. 11, as the runner-up for the 2019 Ohio Faculty Council (OFC) Technology Commercialization Award.
Lin, director of the Orthopaedic Research Laboratories in the UC Department of Orthopaedic Surgery and the Mary S. and Joseph S. Stern Jr. Endowed Chair in Musculoskeletal Research, was recognized for his work in developing Amplicore, a biopharmaceutical company specializing in a unique approach for aiding soft skeletal tissue repair. The licensed technology developed by Lin’s company involves a novel pharmaceutical delivery method that has been shown to promote cartilage repair, retard skeletal degenerative diseases and reduce pain and inflammation.
The award went to Ohio State University’s Katrina Cornish for her accomplishments in developing and licensing technology that can extract material from the guayule shrub, which can yield sustainable natural rubber latex products.
Lin says he is honored to be this year's runner-up.
“Receiving the honor is a great encouragement from the state government to recognize our endeavors,” says Lin. “The award also shows the leadership is determined to foster biotechnologies in the state of Ohio and make the place as an emerging cluster for investors who normally only seek opportunities at coastal bio-hubs.”
Lin’s recognition is a reflection of the emphasis UC places on academic excellence and innovation in its strategic direction, Next Lives Here.
“Faculty in the state of Ohio make a profound impact on students and on the health of our economy, and the OFC celebrates the role our excellent faculty play in economic development,” notes Marc Scott, acting OFC chair. “Dr. Cornish’s and Dr. Lin’s work are stellar examples of the impact faculty make across Ohio. Without Ohio’s investment in higher education and commitment to academic freedom, we would have far fewer such examples to celebrate.”
The Ohio Faculty Council, which represents faculty at all four-year public universities in Ohio, launched its annual Technology Commercialization Award in 2016 to recognize a faculty member in the state university system for exceptional research, discoveries and the translation of those discoveries into marketable products and services. Ohio Department of Higher Education Vice Chancellor Mike Duffey presented the awards.
“We expect that Amplicore will be the first of a series of startups that develop from his unique blend of engineering and medical research,” says Lin’s nominator Geoffrey Pinski, the director of Tech Transfer at UC’s Office of Innovation.
This is the second innovation recognition that Lin has received in 2019. MTF Biologics, the world’s largest tissue bank, named Lin this year’s recipient of the J.R. Neff Award. Named in honor of the late orthopaedic surgeon and researcher, James R. Neff, this award goes to an individual whose work in the orthopaedics field “embodies dedication, perseverance and intense curiosity.”
“While treatments for degenerative joint diseases and soft tissue injury still present unmet needs and perhaps the greatest challenges to the orthopaedic medical practice, our new invention to develop novel injectable therapeutics sheds a hope to provide promising alternatives to treat these disorders,” says Lin.
Last year the Ohio Faculty Council recognized Jay Lee, a professor in UC’s College of Engineering and Applied Science, with the Technology Commercialization Award for Lee’s contribution to the field of industrial artificial intelligence. The year prior the recognition went to UC College of Engineering and Applied Science professor Jason Heikenfeld, for developing a suite of new sensor technology in his Novel Devices Lab.Replace with your text
Next Lives Here
Next Lives Here, the University of Cincinnati’s strategic direction, defines our moment and our momentum. More nimble and more robust than a plan, Next Lives Here announces our vision to the world—to lead urban public universities into a new era of innovation, impact, and inclusion.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.